📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
TEJNAKSH HEALTHCARE LIMITEDTEJNAKSHHealthcare Service Provider
Open
14.49
High
14.49
Low
14.01
Close
14.1
Volume
667
Exchange
bse
Time
21-May-2026

Outlook

Score:

0

Rating:

RISKY

Candlestick Pattern

CandlepatternofTejnakshHealthcareis
Opening Marubozu
EstimatedStoplossofTejnakshHealthcareis
14.49
TejnakshHealthcarehasa
Bearishℹ
pattern.
Formationof
Opening Marubozu
candlepatternindicatesTejnakshHealthcarehaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

TejnakshHealthcareisin
Sideways trendℹ
.
PriceofTejnakshHealthcareis
Downℹ
by

3.82

%.
Target
Buy@

11.77

Sell@

16.77

Current@

14.1

Volume

ThetradevolumesofTejnakshHealthcarehavebecome
Deficientℹ
ThevolumetrendforTejnakshHealthcareis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofTejnakshHealthcareis

Down

by

91.57

%

Valuation

ThecurrentmarketpriceofTejnakshHealthcareis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth30crandtotalassetsworth30cr,thebalancesheetofTejnakshHealthcareis:
Balancedℹ
.
Cashflow
TejnakshHealthcarehas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
0% in operatingℹ
50% i.e. ₹ 3cr earned in investingℹ
50% i.e. ₹ 3cr spent in financingℹ
0% in otherℹ
TejnakshHealthcarehas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Downℹ
by

0

%.
57.14% i.e. ₹ 4cr earned in operatingℹ
14.29% i.e. ₹ 1cr spent in investingℹ
28.57% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
Income
TheincomeofTejnakshHealthcareis

₹ 3cr

and

Loss

is:

₹ 0cr

TejnakshHealthcareLossesincreasedby:

0

%andIncomeisUpby:

50

%
TheincomeofTejnakshHealthcareis

₹ 2cr

and

Loss

is:

₹ 0cr

TejnakshHealthcareLossesincreasedby:

0

%andIncomeisDownby:

33.33

%
TheincomeofTejnakshHealthcareis

₹ 3cr

and

Loss

is:

₹ 0cr

TejnakshHealthcareLossesincreasedby:

0

%andIncomeisUpby:

0

%
By using this site you agree to the use of cookies to deliver a better site experience.